Our previous results have unveiled that the treatment with ER stress inducer HA15 can facilitate the infiltration and activation of cytotoxic CD8+T cells to enhance the anti-tumor capacity, which is predicted to be associated with potentiated treatment efficacy of anti-PD-1 immunotherapy [46, 47]. The gene discussed is CD8A; the disease is neoplasm.